A61K 40/423
Vascular endothelial growth factor [vegf]
Official title: {Vascular endothelial growth factor [VEGF]}
A61K40/423 (Vascular endothelial growth factor [vegf]) appears on 4 US grants and 19 published applications in this corpus.
Search patents in A61K- Granted patents
- 4
- Published applications
- 19
- Assignees
- 12
- Inventors
- 43
- Latest grant
- 27 Jul 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of generating tumor-specific T cells27 Jul 2021US 11,071,754 B2Case Western Reserve University
- Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells16 Jul 2019US 10,351,851 B2The Wistar Institute of Anatomy and Biology
- Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells16 Jan 2018US 9,868,951 B2The Wistar Institute of Anatomy and Biology
- Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells5 Jan 2016US 9,226,936 B2The Wistar of Anatomy and Biology
- Anti-vegfa fusion protein, and preparation method therefor and use thereof13 Aug 2026US 2026/0234232 A1Quaerite Biopharm Research (Beijing) Co., Ltd.
- Hla superagonists and uses thereof4 Dec 2025US 2025/0367292 A1University Health Network
- Foxp1-ablated chimeric cells5 Jun 2025US 2025/0179184 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Methods and Compositions Comprising Orthogonal Cytokine Responsive Immune Cells16 Nov 2023US 2023/0364238 A1The Board of Trustees of the Leland Stanford Junior University
- Chimeric cells comprising dendritic cells and endothelial cells resembling tumor endothelium29 Sep 2022US 2022/0306994 A1Therapeutic Solutions International, Inc.
Most cited
By later US patents